South Korea Next Generation Sequencing (NGS) Market to 2032
Overview
The South Korea Next Generation Sequencing (NGS) Market is expected to reach a 598.30 USD Billion by 2032 and is projected to grow at a CAGR of 18.90% from 2025 to 2032.
Revenue, 2024 (USD Billion)
219.89
Forecast, 2032 (USD Billion)
598.30
CAGR, 2024 - 2032
18.90%
Report Coverage
South Korea
South Korea Next Generation Sequencing (NGS) Market 2018-2032 USD Billion
South Korea Next Generation Sequencing (NGS) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 219.89 USD Billion
- Projected Market Size (2032): 598.30 USD Billion
- CAGR (2025-2032): 18.90%
Key Findings of South Korea Next Generation Sequencing (NGS) Market
- The South Korea Next Generation Sequencing (NGS) Market was valued at 219.89 USD Billion in 2024.
- The South Korea Next Generation Sequencing (NGS) Market is likely to grow at a CAGR of 18.90% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Precision Medicine in Application Segment accounted for the largest share of the market with a revenue of 219.89 USD Billion
- The fastest growing segment Pharmaceuticals Microbiology in Application Segment grew Fastest with a CAGR of 20.04% during the forecast period from 2024 to 2032.
South Korea Next Generation Sequencing (NGS) Market Scope
South Korea Next Generation Sequencing (NGS) Market Segmentation & Scope
Product & Service
- Instruments
- Services
- Consumables
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
South Korea Next Generation Sequencing (NGS) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 219.89 USD Billion |
| Market Value in 2032 | 598.30 USD Billion |
| CAGR (2025-2032) | 18.90% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Product & Service,Distribution Channel,End User,Application,Technology |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 219.89 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 219.89 USD Billion in 2024.
Segments and Scope
-
South Korea Next Generation Sequencing (NGS) Market to 2032, By Product & Service
- Consumables is the largest segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a revenue of 114.70 USD Billion in the year 2024.
- Services is the Fastest growing segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 18.81 % in forecast period 2025-2032.
-
South Korea Next Generation Sequencing (NGS) Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a revenue of 136.23 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 19.12 % in forecast period 2025-2032.
-
South Korea Next Generation Sequencing (NGS) Market to 2032, By End User
- Pharmaceutical & Biotechnology Companies is the largest segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a revenue of 91.35 USD Billion in the year 2024.
- Pharmaceutical & Biotechnology Companies is the Fastest growing segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 19.75 % in forecast period 2025-2032.
-
South Korea Next Generation Sequencing (NGS) Market to 2032, By Application
- Precision Medicine is the largest segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a revenue of 219.89 USD Billion in the year 2024.
- Pharmaceuticals Microbiology is the Fastest growing segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 18.90 % in forecast period 2025-2032.
-
South Korea Next Generation Sequencing (NGS) Market to 2032, By Technology
- Sequencing By Synthesis (SBS) is the largest segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a revenue of 137.13 USD Billion in the year 2024.
- Sequencing By Synthesis (SBS) is the Fastest growing segment in South Korea Next Generation Sequencing (NGS) Market to 2032 with a Growth rate of 19.22 % in forecast period 2025-2032.
South Korea Next Generation Sequencing (NGS) Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Thermo Fisher Scientific Inc. | |||
| QIAGEN | |||
| Charles River Laboratories | |||
South Korea Next Generation Sequencing (NGS) Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Next Generation Sequencing (NGS) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Distribution Channel,End User,Application,Technology.
South Korea Next Generation Sequencing (NGS) Market was valued at USD 219.89(Revenue in USD Billion) in 2020.
South Korea Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 18.90% during the forecast period of 2024 to 2032.
The Precision Medicine segment is expected to dominate the South Korea Next Generation Sequencing (NGS) Market, holding a largest market share of 219.89 USD Billion in 2024
Coming Soon....
South Korea Next Generation Sequencing (NGS) Market Scope
South Korea Next Generation Sequencing (NGS) Market Segmentation & Scope
Product & Service
- Instruments
- Services
- Consumables
Distribution Channel
- Others
- Retail Sales
- Direct Tender
End User
- Others
- Contract Research Organizations (CROS)
- Clinical Laboratories
- Hospitals & Clinics
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
Application
- Others
- Food Pathogen Screening
- Agricultural & Animal Research
- Diagnostics
- Pharmaceuticals Microbiology
- Precision Medicine
- Drug & Biomarker Discovery
Technology
- Others
- Sequencing By Ligation (SBL)
- Sequencing By Synthesis (SBS)
Frequently Asked Questions
The South Korea Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Distribution Channel,End User,Application,Technology.
South Korea Next Generation Sequencing (NGS) Market was valued at USD 219.89(Revenue in USD Billion) in 2020.
South Korea Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 18.90% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Next Generation Sequencing (NGS) Market for final year is USD 598.30 (USD Billion).
South Korea Next Generation Sequencing (NGS) Market Company Profiling
Frequently Asked Questions
The South Korea Next Generation Sequencing (NGS) Market is segmented based on Segmentation Product & Service,Distribution Channel,End User,Application,Technology.
South Korea Next Generation Sequencing (NGS) Market was valued at USD 219.89(Revenue in USD Billion) in 2020.
South Korea Next Generation Sequencing (NGS) Market is projected to grow at a CAGR of 18.90% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Next Generation Sequencing (NGS) Market for final year is USD 598.30 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.